These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 21073954)
21. Pharmacological characterisation of the mechanisms underlying the relaxant effect of adrenomedullin in the rat carotid artery. Passaglia P; Gonzaga NA; Tirapelli DP; Tirapelli LF; Tirapelli CR J Pharm Pharmacol; 2014 Dec; 66(12):1734-46. PubMed ID: 25117796 [TBL] [Abstract][Full Text] [Related]
22. Augmented endothelium-derived hyperpolarizing factor-mediated relaxations attenuate endothelial dysfunction in femoral and mesenteric, but not in carotid arteries from type I diabetic rats. Shi Y; Ku DD; Man RY; Vanhoutte PM J Pharmacol Exp Ther; 2006 Jul; 318(1):276-81. PubMed ID: 16565165 [TBL] [Abstract][Full Text] [Related]
23. Action of atrial natriuretic peptide (ANP) on dog cerebral arteries: evidence that neurogenic relaxation is not mediated by release of ANP. Okamura T; Inoue S; Toda N Br J Pharmacol; 1989 Aug; 97(4):1258-64. PubMed ID: 2529017 [TBL] [Abstract][Full Text] [Related]
24. [Resistance to hemoconcentration but non hypotensive action of atrial natriuretic peptide in diabetes mellitus induced by streptozocin in the rat]. Valentin JP; Sechi LA; Humphreys MH Arch Mal Coeur Vaiss; 1994 Aug; 87(8):1119-23. PubMed ID: 7755472 [TBL] [Abstract][Full Text] [Related]
25. Inhibition by HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin, of atrial natriuretic peptide-induced relaxation of isolated rabbit aorta through the blockade of guanylyl cyclase-linked receptors. Imura R; Sano T; Goto J; Yamada K; Matsuda Y Mol Pharmacol; 1992 Dec; 42(6):982-90. PubMed ID: 1362244 [TBL] [Abstract][Full Text] [Related]
26. Uterine artery function in a mouse model of pregnancy complicated by diabetes. Stanley JL; Ashton N; Taggart MJ; Davidge ST; Baker PN Vascul Pharmacol; 2009; 50(1-2):8-13. PubMed ID: 18778794 [TBL] [Abstract][Full Text] [Related]
28. Alterations in atrial natriuretic peptide and its receptor levels in long-term, streptozotocin-induced, diabetes in rats. Obineche E; Chandranath I; Adeghate E; Benedict S; Fahim M; Adem A Ann N Y Acad Sci; 2006 Nov; 1084():223-34. PubMed ID: 17151304 [TBL] [Abstract][Full Text] [Related]
29. Lipopolysaccharide alters vasodilation to atrial natriuretic peptide via nitric oxide and endothelin-1: time-dependent effects. Scicluna JK; Mansart A; Ross JJ; Reilly CS; Brown NJ; Brookes ZL Eur J Pharmacol; 2009 Oct; 621(1-3):67-70. PubMed ID: 19737554 [TBL] [Abstract][Full Text] [Related]
30. Heart specific up-regulation of genes for B-type and C-type natriuretic peptide receptors in diabetic mice. Christoffersen C; Bartels ED; Nielsen LB Eur J Clin Invest; 2006 Feb; 36(2):69-75. PubMed ID: 16436087 [TBL] [Abstract][Full Text] [Related]
31. Atrial natriuretic peptide signal pathway upregulated in stomach of streptozotocin-induced diabetic mice. Qiu ZX; Mei B; Wu YS; Huang X; Wang ZY; Han YF; Lu HL; Kim YC; Xu WX World J Gastroenterol; 2010 Jan; 16(1):48-55. PubMed ID: 20039448 [TBL] [Abstract][Full Text] [Related]
32. Selective and tone-dependent vasodilation of arterial segment in rabbit and feline pulmonary microcirculation in response to ANP. Shirai M; Ninomiya I; Shindo T Jpn J Physiol; 1993; 43(4):485-99. PubMed ID: 8114359 [TBL] [Abstract][Full Text] [Related]
33. [Comparison of vasorelaxing actions of vasonatrin peptide, C-type natriuretic peptide and atrial natriuretic peptide]. Feng HS; Zang YM; Zhu MZ; Pei JM; Wang YM; Wang L; Shi PT Sheng Li Xue Bao; 1999 Oct; 51(5):515-20. PubMed ID: 11498948 [TBL] [Abstract][Full Text] [Related]
34. Mechanisms underlying reduced P2Y(1) -receptor-mediated relaxation in superior mesenteric arteries from long-term streptozotocin-induced diabetic rats. Ishida K; Matsumoto T; Taguchi K; Kamata K; Kobayashi T Acta Physiol (Oxf); 2013 Jan; 207(1):130-41. PubMed ID: 22759594 [TBL] [Abstract][Full Text] [Related]
35. Attenuated release of atrial natriuretic peptide and vasorelaxation in streptozotocin-induced diabetic rats. Choi KC; Park HC; Lee J J Korean Med Sci; 1994 Apr; 9(2):101-6. PubMed ID: 7986384 [TBL] [Abstract][Full Text] [Related]
36. Involvement of the atrial natriuretic peptide in the reduction of arterial pressure induced by swimming but not by running training in hypertensive rats. Endlich PW; Firmes LB; Gonçalves WL; Gouvea SA; Moysés MR; Bissoli NS; Reis AM; Abreu GR Peptides; 2011 Aug; 32(8):1706-12. PubMed ID: 21762739 [TBL] [Abstract][Full Text] [Related]
37. The role of reactive oxygen species in the modulation of the contraction induced by angiotensin II in carotid artery from diabetic rat. Pernomian L; Santos Gomes M; Baraldi Araujo Restini C; Naira Zambelli Ramalho L; Renato Tirapelli C; Maria de Oliveira A Eur J Pharmacol; 2012 Mar; 678(1-3):15-25. PubMed ID: 22227335 [TBL] [Abstract][Full Text] [Related]
38. Interrelation of coronary effects of atrial natriuretic peptide and the renin-angiotensin system in the isolated perfused rat heart. Bauer WR; Neubauer S; Obitz G; Ertl G J Mol Cell Cardiol; 1994 Apr; 26(4):527-37. PubMed ID: 8072008 [TBL] [Abstract][Full Text] [Related]
39. Effects of different natriuretic peptides on nitric oxide synthesis in macrophages. Kiemer AK; Vollmar AM Endocrinology; 1997 Oct; 138(10):4282-90. PubMed ID: 9322941 [TBL] [Abstract][Full Text] [Related]
40. Renal actions of atrial natriuretic peptide in spontaneously hypertensive rats: the role of nitric oxide as a key mediator. Elesgaray R; Caniffi C; Savignano L; Romero M; Mac Laughlin M; Arranz C; Costa MA Am J Physiol Renal Physiol; 2012 Jun; 302(11):F1385-94. PubMed ID: 22378819 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]